These medications are clopidogrel (Plavix), aspirin/extended release dipyridamole (Aggrenox), and ticlopidine (Ticlid). Carotid Endarterectomy: In many ...
These medications are clopidogrel (Plavix), aspirin/extended release dipyridamole (Aggrenox), and ticlopidine (Ticlid). Carotid Endarterectomy: In many ...
Last week, privately held German firm Boehringer Ingelheim sued Barr over its generic version of Boehringer's Aggrenox, which is used to reduce the risk of ...
The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Aggrenox. ...
Aggrenox had sales of about $258 million in the United States last year, Barr said, citing industry data. This entry was posted by Jerry Gleeson on Thursday ...
Barr Pharma confirms patent challenge of Aggrenox Co confirmed that its subsidiary, Barr Laboratories, has initiated a challenge of the patent listed by ...
... its application with the Food and Drug Administration to produce a generic version of Boehringer's Aggrenox, which is used to reduce the risk of stroke. ...
WOODCLIFF LAKE, NJ, July 12 (UPI) -- US firm Barr said Thursday it is challenging the patent on Boehringer Ingelheim's stroke drug Aggrenox so it can make a ...
The better absorption properties of Aggrenox® were also discussed by Professor Hartmut Derendorf of the University of Florida, USA in a symposium at the ...
The better absorption properties of Aggrenox® were also discussed by Professor Hartmut Derendorf of the University of Florida, USA in a symposium at the ...